Mabwell(SH:688062) Shang Hai Zheng Quan Bao·2025-10-13 00:02Group 1 - In September, over 900 private equity firms participated in A-share listed company research activities, totaling nearly 2800 research instances [1] - The favored sectors for private equity research include electronics, machinery, pharmaceuticals, and power equipment, indicating a structural market trend supported by policies and capital [1][2] - The focus on technology and pharmaceuticals is expected to continue, with private equity showing particular interest in high-quality growth companies amidst market fluctuations [2][3] Group 2 - The biotechnology company Maiwei Bio received significant attention, with 88 private equity firms conducting research, highlighting interest in its dual-target small nucleic acid drugs and α-syn targeting tracer projects [2] - The electronics sector had the highest research frequency in September, with 78 companies being researched 554 times, followed closely by machinery equipment with 444 instances [3] - Investment firms are optimistic about the electronic sector's leading companies and strong pharmaceutical firms with robust fundamentals and R&D advantages [3]